Filter News
Area of Research
- (-) Neutron Science (13)
- Biology and Environment (82)
- Clean Energy (25)
- Climate and Environmental Systems (1)
- Computational Biology (2)
- Fuel Cycle Science and Technology (1)
- Fusion and Fission (1)
- Isotopes (1)
- Materials (9)
- Materials for Computing (5)
- National Security (40)
- Nuclear Science and Technology (1)
- Supercomputing (27)
News Topics
- (-) Biology (5)
- (-) Coronavirus (8)
- (-) National Security (2)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (6)
- Biomedical (11)
- Biotechnology (1)
- Chemical Sciences (2)
- Clean Water (2)
- Climate Change (1)
- Composites (1)
- Computer Science (13)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (14)
- Materials Science (23)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (10)
- Neutron Science (100)
- Nuclear Energy (3)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (2)
- Transportation (5)
Media Contacts
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Paul Langan will join ORNL in the spring as associate laboratory director for the Biological and Environmental Systems Science Directorate.
ORNL researchers used the nation’s fastest supercomputer to map the molecular vibrations of an important but little-studied uranium compound produced during the nuclear fuel cycle for results that could lead to a cleaner, safer world.
Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.